[ad_1] GUANGZHOU, China, 28 de octubre de 2024 /PRNewswire/ — La 136ª Feria de Cantón, que en su segunda fase ha reunido a 10.040 empresas participantes in situ, ha mostrado en línea más de 300.000 productos […]
Trending Stories
CluePoints Appoints Richard Young as Chief Strategy Officer
[ad_1] KING OF PRUSSIA, Pa., Oct. 28, 2024 /PRNewswire/ — RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical […]
Remarks by IMF Managing Director Kristalina Georgieva at the 2024 ESG Global Leaders Conference
[ad_1] SHANGHAI, Oct. 28, 2024 /PRNewswire/ — The 2024 ESG Global Leaders Conference took place in Shanghai from October 16 to 18, where Kristalina Georgieva, Managing Director of the International Monetary Fund (IMF), delivered a […]
WuXi Biologics Launches WuXia™ RidGS for Non-Antibiotic Cell Line Development
[ad_1] SHANGHAI, Oct. 28, 2024 /PRNewswire/ — WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia™ RidGS, a high-yield glutamine synthetase (GS)-knockout Chinese […]
Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
[ad_1] Monday, October 28, 2024, at 8:30 a.m. EDT DUBLIN and CHICAGO, Oct. 28, 2024 /PRNewswire/ — WHO: Iterum Therapeutics plc (Nasdaq: ITRM) is focused on deliveringdifferentiated anti-infectives aimed at combatting the global crisis of multi-drugresistant […]
